BP
JNJ icon

Ballentine Partners’s Johnson & Johnson JNJ Stock Holding History

Ballentine Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Buy
66,025
+6,541
+11% +$1.52M 0.2% 51
2026
Q1 		$14.5M Buy
59,484
+3,630
+6% +$846K 0.2% 49
2025
Q4 		$11.6M Buy
55,854
+1,261
+2% +$249K 0.16% 55
2025
Q3 		$10.1M Buy
54,593
+2,866
+6% +$491K 0.14% 56
2025
Q2 		$7.9M Sell
51,727
-7,313
-12% -$1.12M 0.12% 64
2025
Q1 		$9.79M Buy
59,040
+1,187
+2% +$186K 0.17% 51
2024
Q4 		$8.37M Buy
57,853
+1,461
+3% +$226K 0.14% 56
2024
Q3 		$9.14M Buy
56,392
+4,273
+8% +$681K 0.16% 53
2024
Q2 		$7.62M Sell
52,119
-308
-0.6% -$45.8K 0.14% 56
2024
Q1 		$8.29M Buy
52,427
+7,674
+17% +$1.22M 0.16% 55
2023
Q4 		$7.01M Sell
44,753
-3,092
-6% -$474K 0.14% 57
2023
Q3 		$7.45M Sell
47,845
-2,792
-6% -$461K 0.18% 49
2023
Q2 		$8.38M Buy
50,637
+14,909
+42% +$2.41M 0.19% 46
2023
Q1 		$5.54M Sell
35,728
-5,392
-13% -$871K 0.14% 58
2022
Q4 		$7.26M Buy
41,120
+4,725
+13% +$816K 0.22% 45
2022
Q3 		$5.95M Buy
36,395
+4,177
+13% +$707K 0.21% 44
2022
Q2 		$5.72M Sell
32,218
-450
-1% -$80.2K 0.2% 47
2022
Q1 		$5.79M Buy
32,668
+5,310
+19% +$904K 0.18% 48
2021
Q4 		$4.68M Buy
27,358
+3,368
+14% +$551K 0.14% 56
2021
Q3 		$3.87M Sell
23,990
-53
-0.2% -$9.04K 0.13% 54
2021
Q2 		$3.96M Buy
24,043
+1,369
+6% +$227K 0.14% 51
2021
Q1 		$3.73M Buy
22,674
+507
+2% +$82K 0.14% 52
2020
Q4 		$3.49M Sell
22,167
-2,710
-11% -$400K 0.14% 51
2020
Q3 		$3.7M Sell
24,877
-625
-2% -$92.5K 0.16% 51
2020
Q2 		$3.59M Buy
25,502
+457
+2% +$66.6K 0.17% 51
2020
Q1 		$3.28M Buy
25,045
+124
+0.5% +$17.6K 0.19% 51
2019
Q4 		$3.63M Sell
24,921
-98
-0.4% -$13.3K 0.16% 53
2019
Q3 		$3.24M Buy
25,019
+53
+0.2% +$6.98K 0.15% 60
2019
Q2 		$3.48M Buy
24,966
+3,708
+17% +$513K 0.17% 58
2019
Q1 		$2.97M Buy
21,258
+56
+0.3% +$7.5K 0.15% 54
2018
Q4 		$2.73M Sell
21,202
-1,613
-7% -$225K 0.16% 54
2018
Q3 		$3.15M Sell
22,815
-84
-0.4% -$11.2K 0.16% 49
2018
Q2 		$2.78M Buy
22,899
+830
+4% +$104K 0.15% 53
2018
Q1 		$2.83M Sell
22,069
-2,110
-9% -$285K 0.16% 52
2017
Q4 		$3.38M Sell
24,179
-2,218
-8% -$309K 0.18% 50
2017
Q3 		$3.43M Sell
26,397
-7,053
-21% -$935K 0.19% 50
2017
Q2 		$4.4M Buy
33,450
+18,115
+118% +$2.31M 0.32% 39
2017
Q1 		$1.91M Sell
15,335
-3,892
-20% -$465K 0.14% 41
2016
Q4 		$2.21M Buy
19,227
+1,490
+8% +$172K 0.17% 39
2016
Q3 		$2.1M Sell
17,737
-908
-5% -$110K 0.17% 36
2016
Q2 		$2.26M Sell
18,645
-305
-2% -$34.7K 0.19% 39
2016
Q1 		$2.05M Buy
18,950
+1,089
+6% +$113K 0.18% 41
2015
Q4 		$1.83M Buy
17,861
+293
+2% +$29.5K 0.18% 37
2015
Q3 		$1.64M Buy
17,568
+663
+4% +$64.1K 0.17% 33
2015
Q2 		$1.65M Hold
16,905
– – 0.16% 34
2015
Q1 		$1.7M Sell
16,905
-284
-2% -$28.9K 0.17% 34
2014
Q4 		$1.8M Sell
17,189
-417
-2% -$43.9K 0.21% 32
2014
Q3 		$1.88M Buy
17,606
+54
+0.3% +$5.6K 0.22% 30
2014
Q2 		$1.84M Sell
17,552
-160
-0.9% -$16.2K 0.22% 31
2014
Q1 		$1.74M Buy
17,712
+113
+0.6% +$10.5K 0.2% 32
2013
Q4 		$1.61M Sell
17,599
-1,645
-9% -$152K 0.18% 36
2013
Q3 		$1.67M Buy
19,244
+2,697
+16% +$242K 0.2% 33
2013
Q2 		$1.42M Buy
+16,547
New +$1.4M 0.19% 33

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Ballentine Partners's JNJ Position: Q2 2026 in Review

Ballentine Partners increased its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, buying an estimated $1.52M and bringing the position to 66,025 shares worth $16.8M. The position accounts for 0.2% of the portfolio, ranked #51.

Ballentine Partners first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 1,001 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ballentine Partners held 66,025 shares of Johnson & Johnson worth $16.8M as of Q2 2026.
  • Ballentine Partners bought 6,541 Johnson & Johnson shares in Q2 2026, an estimated $1.52M.
  • Johnson & Johnson made up 0.2% of Ballentine Partners's portfolio in Q2 2026, its #51 holding.
  • Ballentine Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 1,001 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.